Skip to main content

EFECTOS DE LA CONTAMINACION ATMOSFERICA SOBRE EL DESARROLLO DE ARRITMIAS, ESTUDIO DE LOS MECANISMOS, Y ESTRATEGIAS POTENCIALES DE PREVENCION.

PI20/01649

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Execution centre INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis, protective effects of antioxidant cerium oxide nanoparticles

  • Ganse, Freddy G
  • Ernst, Lena M.|||0000-0002-5713-7513
  • Rodríguez Antona, Cristina|||0000-0001-8750-7338
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Inserte, Javier|||0000-0003-2283-3591
  • Martínez-González, José|||0000-0002-3894-7166
  • Briones, Ana|||0000-0001-8218-5579
  • Consegal, Marta|||0000-0002-9201-9117
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Yáñez-Bisbe, Laia|||0000-0001-9084-7296
  • Pomposo, Aitor
  • Prades, Marta
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Puntes, Víctor|||0000-0001-8996-9499
  • Benito Villabriga, Begoña|||0000-0002-8668-1251
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
Epidemiological studies suggest an association between air pollution and ventricular arrhythmias, with reactive oxygen species (ROS) playing a crucial role. However, the causal relationship and long-term effects remain uncertain, and the effectiveness of interventions aimed at reducing ROS requires further investigation. Here we aimed to evaluate the effects of a 3-weeks exposure to diesel exhaust particles (DEPs) on ventricular arrhythmogenesis, explore the underlying mechanisms, and assess the potential of cerium oxide nanoparticles (CeONP) as a ROS-detoxifying intervention. Sprague-Dawley rats underwent intratracheal instillation of saline without or with DEPs (7.5 g/Kg for 1-3 weeks). Ventricular arrhythmia inducibility was then assessed in isolated hearts using a protocol of programmed electrical stimulation. Cardiac hypertrophy, collagen content, inflammation and oxidative stress were analyzed using histology, Western blot, RT-qPCR, and measurement of malondialdehyde content. The potential protective effects of CeONP (0.5 mg/Kg/week, i.p.) were also tested. DEP exposure for 3 weeks increased the incidence and duration of sustained ventricular tachyarrhythmias (VTs), a finding that correlated with a moderate increase in interstitial collagen (from 3.11 ± 0.12% in controls to 4.80 ± 0.21% in DEP-exposed rats, p. < 0.001), and an early upregulation in the expression of collagen and other fibrotic and inflammatory markers. These effects associated with prolonged QRS complex and enhanced malondialdehyde content (356.7 ± 21.2 vs. 455.3 ± 17.2 μmol/g tissue, p = 0.0066) after 3 weeks. CeO2NP treatment reduced oxidative stress and myocardial fibrosis, reversed electrocardiographic changes and attenuated DEP-induced pro-arrhythmic effects. Conclusions: DEP exposure increases the incidence and duration of sustained VTs, collagen deposition and oxidative stress in rats. Treatment with CeO2NP attenuate these effects, arising as a potential novel strategy to mitigate the deleterious effects of air pollution.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel pharmacological approaches in abdominal aortic aneurysm

  • Puertas-Umbert, Lídia
  • Almendra-Pegueros, Rafael
  • Jiménez-Altayó, Francesc
  • Sirvent, Marc
  • Galán, María
  • Martínez-González, José
  • Rodríguez-Sinovas, Cristina
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health issue with an unmet medical need for therapy. This disease is featured by a progressive dilation of the abdominal aorta, boosted by atherosclerosis, ageing, and smoking as major risk factors. Aneurysm growth increases the risk of aortic rupture, a life-threatening emergency with high mortality rates. Despite the increasing progress in our knowledge about the etiopathology of AAA, an effective pharmacological treatment against this disorder remains elusive and surgical repair is still the unique available therapeutic approach for high-risk patients. Meanwhile, there is no medical alternative for patients with small aneurysms but close surveillance. Clinical trials assessing the efficacy of antihypertensive agents, statins, doxycycline, or anti-platelet drugs, among others, failed to demonstrate a clear benefit limiting AAA growth, while data from ongoing clinical trials addressing the benefit of metformin on aneurysm progression are eagerly awaited. Recent preclinical studies have postulated new therapeutic targets and pharmacological strategies paving the way for the implementation of future clinical studies exploring these novel therapeutic strategies. This review summarises some of the most relevant clinical and preclinical studies in search of new therapeutic approaches for AAA., This research was funded by the Spanish Ministerio de Ciencia e Innovación (PID2021-122509OB-I00) [grant number MCIN/ AEI/10.13039/501100011033]; “ERDF A way of making Europe”; Instituto de Salud Carlos III (ISCIII) [grants numbers PI21/01048 and PI20/01649]; Fundación Española de Arteriosclerosis-Sociedad Española de Arteriosclerosis (Beca de Investigación Básica 2020); and Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. L.P-U. and R.A.-P are supported by a PFIS fellowship (ISCIII)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis: protective effects of antioxidant cerium oxide nanoparticles

  • Ganse, Freddy G.
  • Ernst, Lena M.
  • Rodríguez-Sinovas, Cristina
  • Ruíz-Meana, Marisol
  • Inserte, Javier
  • Martínez-González, José
  • Briones, Ana M.
  • García-Redondo, Ana Belén
  • Consegal, Marta
  • Miró-Casas, Elisabet
  • Yáñez-Bisbe, Laia
  • Pomposo, Aitor
  • Prades-Martínez, Marta
  • Ferreira-González, Ignacio
  • Puntes, Víctor F.
  • Benito, Begoña
  • Rodríguez-Sinovas, Antonio
[Background] Epidemiological studies suggest an association between air pollution and ventricular arrhythmias, with reactive oxygen species (ROS) playing a crucial role. However, the causal relationship and long-term effects remain uncertain, and the effectiveness of interventions aimed at reducing ROS requires further investigation. Here we aimed to evaluate the effects of a 3-weeks exposure to diesel exhaust particles (DEPs) on ventricular arrhythmogenesis, explore the underlying mechanisms, and assess the potential of cerium oxide nanoparticles (CeO2NP) as a ROS-detoxifying intervention., [Results] Sprague–Dawley rats underwent intratracheal instillation of saline without or with DEPs (7.5 g/Kg for 1–3 weeks). Ventricular arrhythmia inducibility was then assessed in isolated hearts using a protocol of programmed electrical stimulation. Cardiac hypertrophy, collagen content, inflammation and oxidative stress were analyzed using histology, Western blot, RT-qPCR, and measurement of malondialdehyde content. The potential protective effects of CeO2NP (0.5 mg/Kg/week, i.p.) were also tested. DEP exposure for 3 weeks increased the incidence and duration of sustained ventricular tachyarrhythmias (VTs), a finding that correlated with a moderate increase in interstitial collagen (from 3.11 ± 0.12% in controls to 4.80 ± 0.21% in DEP-exposed rats, p < 0.001), and an early upregulation in the expression of collagen and other fibrotic and inflammatory markers. These effects associated with prolonged QRS complex and enhanced malondialdehyde content (356.7 ± 21.2 vs. 455.3 ± 17.2 μmol/g tissue, p = 0.0066) after 3 weeks. CeO2NP treatment reduced oxidative stress and myocardial fibrosis, reversed electrocardiographic changes and attenuated DEP-induced pro-arrhythmic effects., [Conclusions] DEP exposure increases the incidence and duration of sustained VTs, collagen deposition and oxidative stress in rats. Treatment with CeO2NP attenuate these effects, arising as a potential novel strategy to mitigate the deleterious effects of air pollution., This work was supported by Instituto de Salud Carlos III (grants PI20/01649 and CIBERCV) and Ministerio de Ciencia e Innovación (FORTALECE-FORT23/0034), co-funded by the European Union (European Regional Development Fund, ERDF-FEDER, a way to build Europe), and Generalitat de Catalunya (PERIS STL028/23/00195 and AGAUR-2021SGR758). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond

  • Rodríguez Sinovas, Antonio
  • Corrales Insa, Irene
  • Alonso Nieto, Judith
  • Ballester-Servera, Carme
  • Cañes Esteve, Laia
  • Rodriguez, Cristina
  • Martínez-González, José
Aneurisma aórtico abdominal; Aterosclerosis; Remodelación cardiovascular, Aneurisma aòrtic abdominal; Aterosclerosi; Remodelació cardiovascular, Abdominal aortic aneurysm; Atherosclerosis; Cardiovascular remodeling, The mechanisms committed in the activation and response of vascular and inflammatory immune cells play a major role in tissue remodeling in cardiovascular diseases (CVDs) such as atherosclerosis, pulmonary arterial hypertension, and abdominal aortic aneurysm. Cardiovascular remodeling entails interrelated cellular processes (proliferation, survival/apoptosis, inflammation, extracellular matrix (ECM) synthesis/degradation, redox homeostasis, etc.) coordinately regulated by a reduced number of transcription factors. Nuclear receptors of the subfamily 4 group A (NR4A) have recently emerged as key master genes in multiple cellular processes and vital functions of different organs, and have been involved in a variety of high-incidence human pathologies including atherosclerosis and other CVDs. This paper reviews the major findings involving NR4A3 (Neuron-derived Orphan Receptor 1, NOR-1) in the cardiovascular remodeling operating in these diseases., This research was funded by the Spanish Ministerio de Ciencia e Innovación (RTI2018-094727-B-100), Instituto de Salud Carlos III (ISCIII; PI18/0919 and PI20/01649), the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; 2017-SGR-00333). The study was cofounded by Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. C.B.-S. is supported by a FPU fellowship (Ministerio de Ciencia, Innovación y Universidades).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm: A potential therapeutic opportunity?

  • Puertas-Umbert, Lidia
  • álvarez, saray
  • Ballester-Servera, Carme
  • Alonso Nieto, Judith
  • Aguiló, Silvia
  • Orriols, Mar
  • Rodriguez-Sinovas, Antonio
Abdominal aortic aneurysm, Aneurisma aórtico abdominal, Aneurisma aòrtic abdominal, This work was supported by Instituto de Salud Carlos III (ISCIII) (No. PI21/01048, PI20/01649), the European Regional Development Fund (ERDF-FEDER, a way to build Europe), Ministerio de Ciencia e Innovación (No. RTI2018-094727-B-100), AGAUR (No. 2017-SGR-00333, 2017-SGR-1807) and Consejo Superior de Investigaciones Científicas (No. 2021AEP073). L. P. is supported by a PFIS contract (ISCIII), C.B–S by a FPU fellowship and A.R.-S. and M.G. were funded by the Miguel Servet Program.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Nr4a3, A key nuclear receptor in vascular biology, cardiovascular remodeling and beyond

  • Martínez-González, José|||0000-0002-3894-7166
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Rodríguez, Cristina|||0000-0002-6472-5647
The mechanisms committed in the activation and response of vascular and inflammatory immune cells play a major role in tissue remodeling in cardiovascular diseases (CVDs) such as atherosclerosis, pulmonary arterial hypertension, and abdominal aortic aneurysm. Cardiovascular remodeling entails interrelated cellular processes (proliferation, survival/apoptosis, inflammation, extracellular matrix (ECM) synthesis/degradation, redox homeostasis, etc.) coordinately regulated by a reduced number of transcription factors. Nuclear receptors of the subfamily 4 group A (NR4A) have recently emerged as key master genes in multiple cellular processes and vital functions of different organs, and have been involved in a variety of high-incidence human pathologies including atherosclerosis and other CVDs. This paper reviews the major findings involving NR4A3 (Neuron-derived Orphan Receptor 1, NOR-1) in the cardiovascular remodeling operating in these diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Novel pharmacological approaches in abdominal aortic aneurysm

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • Sirvent, Marc|||0000-0001-5912-8760
  • Galán, María|||0000-0002-4758-8388
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health issue with an unmet medical need for therapy. This disease is featured by a progressive dilation of the abdominal aorta, boosted by atherosclerosis, ageing, and smoking as major risk factors. Aneurysm growth increases the risk of aortic rupture, a life-threatening emergency with high mortality rates. Despite the increasing progress in our knowledge about the etiopathology of AAA, an effective pharmacological treatment against this disorder remains elusive and surgical repair is still the unique available therapeutic approach for high-risk patients. Meanwhile, there is no medical alternative for patients with small aneurysms but close surveillance. Clinical trials assessing the efficacy of antihypertensive agents, statins, doxycycline, or anti-platelet drugs, among others, failed to demonstrate a clear benefit limiting AAA growth, while data from ongoing clinical trials addressing the benefit of metformin on aneurysm progression are eagerly awaited. Recent preclinical studies have postulated new therapeutic targets and pharmacological strategies paving the way for the implementation of future clinical studies exploring these novel therapeutic strategies. This review summarises some of the most relevant clinical and preclinical studies in search of new therapeutic approaches for AAA.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm, A potential therapeutic opportunity?

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Varona, Saray|||0000-0002-7375-313X
  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Aguiló, Silvia|||0000-0003-0672-8388
  • Orriols, Mar
  • Martínez-Martínez, Ernesto
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm: A potential therapeutic opportunity?

  • Puertas-Umbert, Lidia
  • álvarez, saray
  • Ballester-Servera, Carme
  • Alonso Nieto, Judith
  • Aguiló, Silvia
  • Orriols, Mar
  • Rodriguez-Sinovas, Antonio
Abdominal aortic aneurysm, Aneurisma aórtico abdominal, Aneurisma aòrtic abdominal, This work was supported by Instituto de Salud Carlos III (ISCIII) (No. PI21/01048, PI20/01649), the European Regional Development Fund (ERDF-FEDER, a way to build Europe), Ministerio de Ciencia e Innovación (No. RTI2018-094727-B-100), AGAUR (No. 2017-SGR-00333, 2017-SGR-1807) and Consejo Superior de Investigaciones Científicas (No. 2021AEP073). L. P. is supported by a PFIS contract (ISCIII), C.B–S by a FPU fellowship and A.R.-S. and M.G. were funded by the Miguel Servet Program.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond

  • Rodríguez Sinovas, Antonio
  • Corrales Insa, Irene
  • Alonso Nieto, Judith
  • Ballester-Servera, Carme
  • Cañes Esteve, Laia
  • Rodriguez, Cristina
  • Martínez-González, José
Aneurisma aórtico abdominal; Aterosclerosis; Remodelación cardiovascular, Aneurisma aòrtic abdominal; Aterosclerosi; Remodelació cardiovascular, Abdominal aortic aneurysm; Atherosclerosis; Cardiovascular remodeling, The mechanisms committed in the activation and response of vascular and inflammatory immune cells play a major role in tissue remodeling in cardiovascular diseases (CVDs) such as atherosclerosis, pulmonary arterial hypertension, and abdominal aortic aneurysm. Cardiovascular remodeling entails interrelated cellular processes (proliferation, survival/apoptosis, inflammation, extracellular matrix (ECM) synthesis/degradation, redox homeostasis, etc.) coordinately regulated by a reduced number of transcription factors. Nuclear receptors of the subfamily 4 group A (NR4A) have recently emerged as key master genes in multiple cellular processes and vital functions of different organs, and have been involved in a variety of high-incidence human pathologies including atherosclerosis and other CVDs. This paper reviews the major findings involving NR4A3 (Neuron-derived Orphan Receptor 1, NOR-1) in the cardiovascular remodeling operating in these diseases., This research was funded by the Spanish Ministerio de Ciencia e Innovación (RTI2018-094727-B-100), Instituto de Salud Carlos III (ISCIII; PI18/0919 and PI20/01649), the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; 2017-SGR-00333). The study was cofounded by Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. C.B.-S. is supported by a FPU fellowship (Ministerio de Ciencia, Innovación y Universidades).